|
Title
|
Type
|
Submission Type |
Organizer |
Cosponsor |
Description |
| A Medicinal Chemist’s Toolbox: Conformation in Drug Design (Invited) |
Oral |
Invited |
|
|
Conformational control is critical element in drug design that can exert an impact
not only on the p...
|
| Biopharma 101: Transition to Industry (Invited) |
Oral |
Invited |
|
|
|
| Blood-Brain Barrier Transcytosis of Therapeutics for Targeted Delivery to the CNS (Invited) |
Oral |
Invited |
|
|
Therapeutic biomacromolecules, such as peptides, proteins, and oligonucleotides, hold immense promis...
|
| Cannabis and Medicinal Chemistry: A Growing Alliance |
Oral |
Contributed |
|
- CCS: Committee on Chemical Safety
|
As the therapeutic potential of Cannabis sativa and its derivatives garners increasing scientific in...
|
| Degrader-Antibody Conjugates (DACs): Recent Developments, Challenges, and Opportunities (Invited) |
Oral |
Invited |
|
|
Degrader-antibody conjugates (DACs) are an emerging modality where protein degrader molecules (heter...
|
| Drug Discovery Aimed at Neglected and Emerging Parasitic Infections (Invited) |
Oral |
Invited |
|
|
The therapeutic landscape for parasitic infections often relies on repurposed or antiquated
drugs th...
|
| Drugging Transcription Factors: From Privileged Classics to the Next Frontier (Invited) |
Oral |
Invited |
|
|
Transcription factor are proteins which regulate gene expression at the DNA level. They are key dru...
|
| Evolution of Radioligand Therapeutics via Peptide and Small Molecule Conjugates (Invited) |
Oral |
Invited |
|
|
The field of radioligand therapy (RLT) is experiencing significant transformation, particularly with...
|
| Global Virtual Symposium: Tools for Developing Modern Therapeutics |
Oral |
Contributed |
|
|
A critical research gap in medicinal chemistry and chemical biology lies in the translation of innov...
|
| Fluorine in Drug Design: Synthesis, Applications and Environmental Considerations (Invited) |
Oral |
Invited |
|
|
|
| MEDI Awards Session (Invited) |
Oral |
Invited |
|
|
|
| MEDI Celebrates the 150 Years of the ACS!: The Heart of Drug Discovery: CV and Metabolic Innovation Over the Last 150 Years (Invited) |
Oral |
Invited |
|
|
The Division of Medicinal Chemistry celebrates the 150th Anniverary of the ACS by bringing this audi...
|
| MEDI First Time Disclosures (Invited) |
Oral |
Invited |
|
|
|
| MEDI General Orals Session |
Oral |
Contributed |
|
|
|
| MEDI General Orals Session: New Developments in Small Molecule and Beyond-Rule-of-5 Modalities |
Oral |
Contributed |
|
|
|
| MEDI General Orals Session: Novel Targets and Emerging Therapies |
Oral |
Contributed |
|
|
|
| MEDI General Orals Session: Tools and Technologies for the Modern Medicinal Chemist |
Oral |
Contributed |
|
|
|
| Privileged Sulfur-Based Functional Groups in Drug Discovery (Invited) |
Oral |
Invited |
|
|
Sulfur-based functional groups represent an increasingly popular pharmacophore in drug discovery. In...
|
| MEDI General Poster Session |
Poster |
Contributed |
|
|
|
| MEDI General Poster Session: New Developments in Small Molecule and Beyond-Rule-of-5 Modalities |
Poster |
Contributed |
|
|
|
| MEDI General Poster Session: Novel Targets and Emerging Therapies |
Poster |
Contributed |
|
|
|
| MEDI General Poster Session: Tools and Technologies for the Modern Medicinal Chemist |
Poster |
Contributed |
|
|
|
